Document is current
Any future updates will be listed below
-
Authors
Bektaş, Murat https://orcid.org/0000-0002-1788-3837
Çavuş, Bilger https://orcid.org/0000-0003-2203-4255
Ağargün, Besim Fazıl https://orcid.org/0000-0002-3933-1881
Şenkal, İbrahim Volkan https://orcid.org/0000-0002-4363-7197
Koca, Nevzat https://orcid.org/0000-0002-0942-0947
İnce, Burak https://orcid.org/0000-0001-9813-2228
Sarı, Selma https://orcid.org/0000-0001-6839-8164
Dirim, Ahmet Burak https://orcid.org/0000-0003-2262-8627
Mastanzade, Metban Güzel https://orcid.org/0000-0002-2281-5978
Dağcı, Gizem https://orcid.org/0000-0003-3554-4879
Özer, Pelin Karaca https://orcid.org/0000-0002-1085-5462
Aydoğan, Mehmet https://orcid.org/0000-0003-1342-3590
Büyük, Melek https://orcid.org/0000-0003-3425-2137
Yalçınkaya, Yasemin https://orcid.org/0000-0002-9881-6694
Artım-Esen, Bahar https://orcid.org/0000-0002-5659-3955
İnanç, Murat https://orcid.org/0000-0002-6376-5583
Güllüoğlu, Mine https://orcid.org/0000-0002-3967-0779
Yazıcı, Halil https://orcid.org/0000-0003-2526-3483
Beşışık, Sevgi Kalayoğlu https://orcid.org/0000-0002-9310-1278
Beşışık, Selman Fatih https://orcid.org/0000-0001-5184-376X
Gül, Ahmet https://orcid.org/0000-0001-8219-3720
-
Funding
Funding for this research was provided by:
Istanbul University
- License Information
-
More Information
Article History
Received: 6 April 2025
Accepted: 23 May 2025
First Online: 1 July 2025
Declarations
:
: AG declared consultancy and honoraria for Eli Lilly, Novartis, and Sobi; consultancy for Pfizer and R-Pharm. MI declared consultancy and honoraria for Pfizer, MSD, UCB, AbbVie, and Novartis. BG, BFA, IVS, NK, BI, SS, ABD, MGM, GD, PKO, MA, MB, YY, BAE, MG, HY, SKB, and SFB authors declared no disclosure.
: Istanbul Faculty of Medicine Research Ethics Committee approved the study protocol, and all participants provided informed consent for the study (date and number: 19.02.2021–2021/248, and 08.03.2021–107638 for the liver and kidney transient elastography studies, respectively).
